FINNENCE ▪ THE WIRE FILE
THE WIRE · № 71119
News■ Unclear/unknown
Illumina releases SpliceAI2 to help advance rare disease research
KINDNews
DIRECTION■ Unclear/unknown
SOURCES1
ENTITIES1
STORY SIZESTANDALONE
FIRST SEEN2026-10-08 13:15 UTC
LAST UPDATE2026-10-08 13:15 UTC
STATEactive
01 THE MACHINE READ
WHY IT MATTERS.
Genomic AI model improves rare-disease variant detection, supporting research tooling demand.
Genomic AI improves rare-disease variant discovery
CATALYST TO WATCH
Researcher adoption of SpliceAI2
MAIN RISK
Research tooling revenue impact limited
FULL DISPATCH
In a rare disease research dataset, SpliceAI2 identified 17% more disease-relevant variants compared to other splicing models Illumina's genomic AI models now collectively enable researchers to identify 2x as many variants with predicted biological impact SAN DIEGO, Oct. 8, 2026...
02 THE STORY SO FAR
THE RECORD, IN ORDER.
STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.
03 WHO'S INVOLVED
ENTITIES ON FILE.
AFFECTEDHealthcare
04 RECEIPTS
THE SOURCE RECORD.
1 SOURCES CONFIRMED05 PROPAGATION
WHAT THIS TOUCHES.
→CORRELATIONshares Healthcare
IAM IPO News - Small molecule biotech Iambic Therapeutics sets terms for $150 million IPO2026-10-08 12:44 UTC
IAM IPO News - Small molecule biotech Iambic Therapeutics sets terms for $150 million IPO2026-10-08 12:44 UTC
→CORRELATIONshares Healthcare
Iambic aims for $135M IPO to push cancer drugs through clinic2026-10-08 12:45 UTC
Iambic aims for $135M IPO to push cancer drugs through clinic2026-10-08 12:45 UTC
→CORRELATIONshares Healthcare
Money Matters: Oil Prices Increase & Prescription Costs Rise2026-10-08 13:27 UTC
Money Matters: Oil Prices Increase & Prescription Costs Rise2026-10-08 13:27 UTC
→CORRELATIONshares Healthcare
AI drug discovery startup Iambic seeks $150M in IPO2026-10-08 13:41 UTC
AI drug discovery startup Iambic seeks $150M in IPO2026-10-08 13:41 UTC
→CORRELATIONshares Healthcare
Hormonal Facial Hair Is the Menopause Symptom No One Warns Women About2026-10-08 14:12 UTC
Hormonal Facial Hair Is the Menopause Symptom No One Warns Women About2026-10-08 14:12 UTC
←CORRELATIONshares Healthcare
Victory Square Announces U.S. Patent Allowance for Insu Therapeutics' Needle-Free Insulin and GLP-1 Delivery Platform2026-10-08 11:30 UTC
Victory Square Announces U.S. Patent Allowance for Insu Therapeutics' Needle-Free Insulin and GLP-1 Delivery Platform2026-10-08 11:30 UTC
KEEP READING THE MACHINE
Summaries are generated and may contain errors — every claim links its sources.